scPharmaceuticals to Present at the Jefferies Global Healthcare Conference
scPharmaceuticals (Nasdaq: SCPH) announced that its CEO, John Tucker, will present at the Jefferies Global Healthcare Conference on June 5, 2024. The presentation will occur at 5:00 PM ET, with Tucker also engaging in meetings with investors throughout the day. The webcast of the presentation will be accessible via the company’s Investor Relations section on its website.
- CEO presentation at Jefferies Global Healthcare Conference enhances visibility.
- Opportunity for direct engagement with investors may boost investor confidence.
- Webcast availability broadens access to the information presented.
- No new product or financial updates were announced.
BURLINGTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, will present at the Jefferies Global Healthcare Conference on Wednesday, June 5 at 5:00PM ET. Mr. Tucker will also be meeting with investors that day.
A webcast of the presentation can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scPharmaceuticals.com.
About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead program focuses on the subcutaneous, self-administration of IV-strength treatment in heart failure. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.
Katherine Miranda
scPharmaceuticals Inc., 781-301-6869
kmiranda@scpharma.com
Investors:
PJ Kelleher
LifeSci Advisors, 617-430-7579
pkelleher@lifesciadvisors.com
![](https://ml.globenewswire.com/media/MGRlOGQ1ZjUtNmUxMi00NWVjLWExZTItOThmZmEzMmM2ZTljLTUwMDA3NTU1Mg==/tiny/scPharmaceuticals-Inc-.png)
FAQ
When is scPharmaceuticals presenting at the Jefferies Global Healthcare Conference?
What is the stock symbol for scPharmaceuticals?
Where can I access the webcast of scPharmaceuticals' Jefferies Global Healthcare Conference presentation?
Who will be presenting for scPharmaceuticals at the Jefferies Global Healthcare Conference?